Novel oral anticoagulants.

@article{Reiffel2014NovelOA,
  title={Novel oral anticoagulants.},
  author={James A. Reiffel},
  journal={The American journal of medicine},
  year={2014},
  volume={127 4},
  pages={e16-7}
}
Warfarin has a proven record as an oral anticoagulant; almost every study, however, has found that it is not prescribed for 40-60% of patients who are eligible and should receive it, and of those who do receive it, serum warfarin levels only achieved a time in therapeutic range (TTR) equal to INR 2-3 about 55-60% of the time (online video available at: http://education.amjmed.com/video.php?event_id=445&stage_id=5&vcs=1). This means that only about 1 in 4 patients are adequately anticoagulated… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

Similar Papers

Loading similar papers…